ZA906544B - 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases - Google Patents

5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases

Info

Publication number
ZA906544B
ZA906544B ZA906544A ZA906544A ZA906544B ZA 906544 B ZA906544 B ZA 906544B ZA 906544 A ZA906544 A ZA 906544A ZA 906544 A ZA906544 A ZA 906544A ZA 906544 B ZA906544 B ZA 906544B
Authority
ZA
South Africa
Prior art keywords
acid anilides
hydroxyethylidene
isoxazole
methyl
treatment
Prior art date
Application number
ZA906544A
Other languages
English (en)
Inventor
Stella M Robertson
M Robertson Stella
Laura Smith Lang
Smith Lang Laura
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of ZA906544B publication Critical patent/ZA906544B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA906544A 1989-08-18 1990-08-17 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases ZA906544B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39586089A 1989-08-18 1989-08-18

Publications (1)

Publication Number Publication Date
ZA906544B true ZA906544B (en) 1991-06-26

Family

ID=23564835

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA906544A ZA906544B (en) 1989-08-18 1990-08-17 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases

Country Status (15)

Country Link
EP (1) EP0413329B1 (de)
JP (1) JP3131693B2 (de)
KR (1) KR100192745B1 (de)
AT (1) ATE148628T1 (de)
AU (1) AU633346B2 (de)
CA (1) CA2023560C (de)
DD (1) DD297328A5 (de)
DE (1) DE69029884T2 (de)
DK (1) DK0413329T3 (de)
ES (1) ES2099700T3 (de)
HU (1) HU215959B (de)
IE (1) IE902978A1 (de)
IL (1) IL95412A (de)
TW (1) TW287948B (de)
ZA (1) ZA906544B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2079765T3 (es) * 1991-10-23 1996-01-16 Hoechst Ag Derivados de amidas de acido n-fenil-2-ciano-3-hidroxicrotonico y su utilizacion como medicamento con propiedad inmunomoduladora.
TW314467B (de) * 1993-03-31 1997-09-01 Hoechst Ag
US5700823A (en) * 1994-01-07 1997-12-23 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers
US6335356B1 (en) 1994-01-07 2002-01-01 Sugen, Inc. Method of treating a patient by parenteral administration of a lipophilic compound
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
DK0787491T3 (da) * 1994-10-17 2000-10-16 Aventis Pharma Ltd Middel til forebyggelse og behandling af allergiske sygdomme af type I
US5721277A (en) * 1995-04-21 1998-02-24 Sugen, Inc. Compounds and methods for inhibiting hyper-proliferative cell growth
US6331555B1 (en) 1995-06-01 2001-12-18 University Of California Treatment of platelet derived growth factor related disorders such as cancers
US6011051A (en) * 1996-07-31 2000-01-04 Hoechst Aktiengesellschaft Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
US6316479B1 (en) 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
DE102006017896A1 (de) † 2006-04-13 2007-10-25 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Leflunomid enthaltende pharmazeutische Zusammensetzungen
WO2015169944A1 (en) * 2014-05-08 2015-11-12 Panoptes Pharma Ges.M.B.H. Compounds for treating ophthalmic diseases and disorders
WO2023182871A1 (ko) * 2022-03-25 2023-09-28 바스테라 주식회사 3-페닐이속사졸 유도체 및 이를 유효성분으로 함유하는 안질환 예방 또는 치료용 약학 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES448386A1 (es) * 1975-06-05 1978-04-16 Hoechst Ag Procedimiento para la preparacion de anilidas de acido 5-me-til-isoxazol-4-carboxilico.
NL186239B (nl) 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2854439A1 (de) 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
AU633346B2 (en) 1993-01-28
JP3131693B2 (ja) 2001-02-05
AU6110490A (en) 1991-02-21
DE69029884D1 (de) 1997-03-20
IL95412A0 (en) 1991-06-30
CA2023560C (en) 2000-12-12
IL95412A (en) 1996-01-31
JPH0390024A (ja) 1991-04-16
EP0413329B1 (de) 1997-02-05
TW287948B (de) 1996-10-11
EP0413329A3 (en) 1992-04-15
ATE148628T1 (de) 1997-02-15
EP0413329A2 (de) 1991-02-20
HU215959B (hu) 1999-03-29
IE902978A1 (en) 1991-02-27
HU905064D0 (en) 1991-01-28
HUT59600A (en) 1992-06-29
DD297328A5 (de) 1992-01-09
ES2099700T3 (es) 1997-06-01
DE69029884T2 (de) 1997-08-14
CA2023560A1 (en) 1991-02-19
KR910004193A (ko) 1991-03-28
DK0413329T3 (da) 1997-08-18
KR100192745B1 (ko) 1999-06-15

Similar Documents

Publication Publication Date Title
KR0125921B1 (en) Method and device for the diagnosis and treatment of nasal diseases
AP9000206A0 (en) Treatment of conditions & diseases
AU6760987A (en) Method of treating alzheimer's disease
BR9007938A (pt) Metodo e aparelho o tratamento de glaucoma
ZA906544B (en) 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular diseases
ZM9387A1 (en) Treatment of diseases caused by viruses
ZA896150B (en) The use of alpha-amino boronic acid derivatives for the prophylaxis and treatment of virus diseases
ZA90245B (en) Treatment of diseases associated with hiv infections
ES2063060T3 (es) Benzamida contra enfermedades cognoscitivas.
EP0506893A4 (en) Diagnosis and treatment of diseases
ZA871528B (en) The treatment of diseases of the immune system with diphenylhydantoin and its derivatives
ZA824983B (en) Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
PH24568A (en) Use of bezafibrate for treating diabetes
ZA878055B (en) A therapeutically useful compound
TW221376B (de)
SE8102161L (sv) "3,7,11,15-tetrametyl-2,4,6,10,14-hexadekapentaensyra
NO179245C (no) Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet
EP0436717A4 (en) Method of treatment with medical agents
EP0407788A3 (en) Use of retinoids for the treatment and prophylaxis of immune related diseases
ZA9010081B (en) Method for the treatment of glaucoma
AU7931487A (en) Therapeutic treatment of abnormal cell growth with follicle regulatory protein
SU1405143A1 (ru) Способ лечения острых нарушений мозгового кровообращения
NO912528D0 (no) Behandling av sykdommer forbundet med jodmangel.
AU588493B2 (en) Treatment of diseases caused by viruses
IE892593L (en) Treatment of virus diseases